Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04284904

Role of aGVHD Biomarkers on aGVHD Risks

Sponsor: Chinese PLA General Hospital

View on ClinicalTrials.gov

Summary

To establish risk rating criteria of biological protein marker, determine the role and consistency of aGVHD biomarkers in aGVHD diagnosis and aGVHD prognosis, and evaluate the the impact on non-relapse mortality and relapse and disease free survival, the multicenter study on aGVHD biomarkers detection in the patients underwent allogeneic hematopoietic stem cell transplantation was performed.

Official title: Role of aGVHD Biomarkers on aGVHD Risks in Patients Underwent Hematopoietic Stem Cell Transplantation

Key Details

Gender

All

Age Range

0 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2019-02-01

Completion Date

2023-12-31

Last Updated

2026-05-05

Healthy Volunteers

Not specified

Interventions

DIAGNOSTIC_TEST

aGVHD biomarker

To verify the effectiveness of aGVHD biomarkers monitoring in predicting aGVHD risks

Locations (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China